Cassava Sciences, Inc.
SAVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $200 | $5,116 | $13,666 | $20,530 |
| Gross Profit | -$200 | -$5,116 | -$13,666 | -$20,530 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,955 | $5,116 | $13,666 | $20,530 |
| G&A Expenses | $0 | $8,976 | $7,920 | $943 |
| SG&A Expenses | $7,705 | $8,976 | $7,920 | $943 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $26,184 | -$10,666 | -$12,516 |
| Operating Expenses | $11,660 | $40,276 | $10,920 | $8,957 |
| Operating Income | -$11,860 | -$45,392 | -$24,586 | -$29,487 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,053 | $1,168 | $1,183 | $1,890 |
| Pre-Tax Income | -$10,807 | -$44,224 | -$23,403 | -$27,597 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,807 | -$44,224 | -$23,403 | -$27,597 |
| % Margin | – | – | – | – |
| EPS | -0.22 | -0.92 | -0.48 | -0.57 |
| % Growth | 76.1% | -91.7% | 15.8% | – |
| EPS Diluted | -0.22 | -0.92 | -0.48 | -0.57 |
| Weighted Avg Shares Out | 48,293 | 48,308 | 48,262 | 48,099 |
| Weighted Avg Shares Out Dil | 48,293 | 48,308 | 48,262 | 48,099 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,167 | $1,214 | $1,265 | $1,800 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $200 | $218 | $220 | $260 |
| EBITDA | -$10,607 | -$13,874 | -$21,366 | -$19,327 |
| % Margin | – | – | – | – |